There was neither significant difference in IGF-1 level between subjects with the cluster of four MetS risk factors and subjects without the cluster of four MetS risk factors (Fig. 3G) nor between central obese and non-central obese subjects (Fig. 3H). This evidence concerns the gene IGF1 and metabolic syndrome.